Oxford Biomedica financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
£0.50M £0.82M £0.76M £7.22M £18.39M £19.12M £11.15M £7.72M £7.76M £5.38M £13.62M £15.91M £27.78M £37.59M £66.78M £64.06M £87.73M £142.80M £139.99M £89.54M £0.00M
GM % Gross Margin %
100.00% 100.00% 100.00% 93.78% 92.96% 100.47% 105.32% 92.81% 91.40% 78.79% 67.57% 63.30% 57.39% 50.94% 50.19% 44.24% 52.52% 82.64% 49.42% 44.37% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% -269.91% -49.53% -8.59% -72.29% -146.44% -135.21% -238.57% -77.93% -88.52% -40.73% -21.19% 11.88% -19.64% -5.54% -0.10% -33.19% -96.03% 0.00%
EPS Earnings Per Share
£-1.20 £-1.75 £-1.42 £-0.50 £-0.88 £-0.50 £-0.51 £-0.38 £-0.40 £-0.22 £-0.26 £-0.30 £-0.22 £0.11 £-0.20 £-0.07 £0.23 £-0.63 £-0.64 £0.00
Div. Dividends
£0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00
PR % Payout Ratio %
0 -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% 0.00% -0.00% -0.00% 0.00% -0.00% -0.00% 0
Sha. Shares
7.44m 7.44m 9.97m 10.03m 10.74m 10.82m 10.9m 18.9m 28.16m 28.32m 51.31m 51.35m 61.65m 62.06m 66.09m 76.85m 77m -122.72m 96.06m 96.8m 99.96m
OCF Operating Cash Flow
£-9.26M £-7.32M £-15.66M £6.30M £-15.97M £2.31M £-12.83M £-12.98M £-10.04M £-11.02M £-6.03M £-13.12M £-1.85M £2.98M £12.87M £-3.51M £3.12M £12.66M £-12.62M £-28.52M £0.00M
FCF Free Cash Flow
£-9.58M £-7.65M £-15.85M £6.04M £-16.90M £2.06M £-13.12M £-16.62M £-10.51M £-11.86M £-11.61M £-29.84M £-8.31M £1.01M £2.77M £-29.28M £-10.24M £15.99M £-28.91M £-55.25M £0.00M
FCFS Free Cash Flow Per Share
£-1.32 £-1.01 £-1.59 £0.56 £-1.57 £0.19 £-1.23 £-0.89 £-0.47 £-0.42 £-0.29 £-0.58 £-0.15 £0.02 £0.04 £-0.40 £-0.13 £0.19 £-0.30 £-0.40 £0.00